Advancing Therapy in Uncontrolled Basal Insulin-Treated Type 2 Diabetes (T2D): Better Clinical Outcomes with IGlarLixi vs. Premix 70/30 in the SoliMix TrialJulio Rosenstock,Rifat Emral,Leobardo Sauque-Reyna,Viswanathan Mohan,Carlos Trescoli,Saud N. Al Sifri,Nebojsa Lalic,Agustina Alvarez,Pascaline Picard,Nacima Demil,Mireille Bonnemaire,Rory J. McCrimmonDIABETES（2021）引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
